Diabetes

FDA Warning on Compounded Semaglutide Like Ozempic

FDA Warning on Compounded Semaglutide Like Ozempic

The FDA has warned against using compounded formulations of semaglutide, the active ingredient in Ozempic and Wegovy, due to risks like unknown safety, lack of efficacy data, contamination and improper dosing....

Latest news